Clinical Trial Update: Rituximab,Methotrexate and Lenalidomide in Newly Diagnosed Primary Central Nervous System Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating rituximab, methotrexate, and lenalidomide in newly diagnosed primary central nervous system lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• Lenalidomide (lenalidomide)
• METHOTREXATE (METHOTREXATE)
• Rituximab (rituximab)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Primary Central Nervous System Lymphoma | Phase 2 | Status: COMPLETED